Clinical and cost-effectiveness data are vital to gain reimbursement for new technologies in Europe
This article was originally published in Clinica
Executive Summary
The medical device industry must rethink its attitude towards providing clinical and cost-effectiveness data to support the launch of new technologies in Europe.